Stay updated on CF33-hNIS-antiPDL1 in Metastatic TNBC Clinical Trial
Sign up to get notified when there's something new on the CF33-hNIS-antiPDL1 in Metastatic TNBC Clinical Trial page.

Latest updates to the CF33-hNIS-antiPDL1 in Metastatic TNBC Clinical Trial page
- Check2 days agoChange DetectedThe history now shows the addition of revision v3.3.4 and the removal of revision v3.3.3 from the record history. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedA new revision entry, Revision: v3.3.3, was added to the Record History. The HHS Vulnerability Disclosure item and Revision: v3.3.2 were removed.SummaryDifference0.2%

- Check53 days agoChange DetectedRevision entries show v3.3.2 added and v3.2.0 removed; these are minor metadata changes to the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check60 days agoChange DetectedRemoved the notice about potential data delays due to government funding lapses and links to operating-status updates.SummaryDifference0.7%

- Check74 days agoChange DetectedNew screenshot shows the same record history layout with an added version entry (2025-10-02) reflecting an update to NCT05081492. The overall page structure remains unchanged aside from this administrative update.SummaryDifference0.1%

- Check96 days agoChange DetectedAdds a new date and a new Study Status section with a recent timestamp; removes an older date, shifting temporal context forward.SummaryDifference1%

Stay in the know with updates to CF33-hNIS-antiPDL1 in Metastatic TNBC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CF33-hNIS-antiPDL1 in Metastatic TNBC Clinical Trial page.